Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 202
Filtrar
Más filtros

Medicinas Complementárias
Intervalo de año de publicación
1.
J Wound Care ; 33(Sup1a): S10-S14, 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-38194310

RESUMEN

BACKGROUND: There is no clear guidance or comprehensive comparative evidence to help clinicians select between adjustable wraps for compression therapy. However, adjustable wraps could be compared with three metrics used for compression bandages: variation in pressure, stiffness and elasticity. AIMS: To determine whether easywrap (Haddenham Healthcare) had lower standard deviation (SD) in lying pressure, greater static stiffness index (SSI) and/or a greater mean elongation ratio than six other adjustable wraps. METHODS: In this preliminary exploratory study, seven adjustable wraps were tested in vivo 20 times each (140 tests in total), on 20 people (with a variable number of readings per participant), to give the SD in lying pressure and mean SSI. The same wraps were tested in vitro five times each to give the mean elongation ratio. FINDINGS: Of all seven adjustable wraps, easywrap had the second lowest SD in lying pressure at 5.9 mmHg, compared with 8.9 mmHg overall; the highest mean SSI at 13.2 mmHg, compared with 9.5 mmHg overall; and the highest mean elongation ratio at 137.0%, compared with 107.1% overall. CONCLUSIONS: These metrics suggest that easywrap has clinical advantages over other adjustable wraps. A lower variation in lying pressure suggests more consistent application of pressures within intended therapeutic levels. Higher SSI indicates greater resistance to stretching, which is linked to improved venous function and oedema reduction. Higher elongation ratio demonstrates greater tensile strength, which should maintain therapeutic pressure for longer without readjustment.


Asunto(s)
Enfermedades Linfáticas , Humanos , Vendajes de Compresión , Elasticidad , Instituciones de Salud , Masaje
2.
J Wound Care ; 33(Sup1): S10-S14, 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-38150280

RESUMEN

BACKGROUND: There is no clear guidance or comprehensive comparative evidence to help clinicians select between adjustable wraps for compression therapy. However, adjustable wraps could be compared with three metrics used for compression bandages: variation in pressure, stiffness and elasticity. AIMS: To determine whether easywrap (Haddenham Healthcare) had lower standard deviation (SD) in lying pressure, greater static stiffness index (SSI) and/or a greater mean elongation ratio than six other adjustable wraps. METHODS: In this preliminary exploratory study, seven adjustable wraps were tested in vivo 20 times each (140 tests in total), on 20 people (with a variable number of readings per participant), to give the SD in lying pressure and mean SSI. The same wraps were tested in vitro five times each to give the mean elongation ratio. FINDINGS: Of all seven adjustable wraps, easywrap had the second lowest SD in lying pressure at 5.9 mmHg, compared with 8.9 mmHg overall; the highest mean SSI at 13.2 mmHg, compared with 9.5 mmHg overall; and the highest mean elongation ratio at 137.0%, compared with 107.1% overall. CONCLUSIONS: These metrics suggest that easywrap has clinical advantages over other adjustable wraps. A lower variation in lying pressure suggests more consistent application of pressures within intended therapeutic levels. Higher SSI indicates greater resistance to stretching, which is linked to improved venous function and oedema reduction. Higher elongation ratio demonstrates greater tensile strength, which should maintain therapeutic pressure for longer without readjustment.


Asunto(s)
Enfermedades Linfáticas , Humanos , Vendajes de Compresión , Elasticidad , Instituciones de Salud , Masaje
3.
J Vasc Surg Venous Lymphat Disord ; 11(6): 1192-1201.e2, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37442275

RESUMEN

OBJECTIVE: Recent studies have emphasized the important role lymphatics play in the drainage of interstitial fluid and edema prevention. Although the infrainguinal lymphatics have been studied in some depth, with patterns of pathology identified, such data above the groin are sparse, especially for patients with phlebolymphedema. The present study attempts to evaluate the status of lymphatic flow above the inguinal ligament in patients presenting with edema and undergoing stenting for symptomatic chronic iliofemoral venous obstruction (CIVO). METHODS: A total of 31 lower limbs that underwent pedal lymphoscintigraphy for leg edema and subsequent stenting for symptomatic CIVO formed the study cohort. Each limb underwent intranodal lymphangiography of an ipsilateral inferior inguinal lymph node (10 mL of lipiodol) at the time of stenting. Fluoroscopic visualization of lipiodol transit was performed at 20, 40, and 60 minutes and 3 hours after injection. Enumeration of the lymph nodes and lymphatic collector vessels from above the inguinal ligament to L1, visualization of the thoracic duct, the time delay to visualization of the thoracic duct, and pathologic changes to the thoracic duct when present were all evaluated. These anomalies were independently scored, with the scores combined to generate a total suprainguinal score (range, 0-3). This score was then compared to the limb's lymphoscintigraphically derived infrainguinal score (total infrainguinal score range, 0-3) using the t test and Spearman correlation. The clinical outcomes (grade of swelling, venous clinical severity score) after stenting were appraised. RESULTS: Of the 30 patients (31 limbs), 18 were women, with left laterality noted in 23 limbs. A nonthrombotic iliac vein lesion occurred in 9 limbs and post-thrombotic syndrome in 22 limbs. Of the 31 limbs, 24 (77%) had suprainguinal lymphatic disease (SLD), with 22 of the 24 limbs having severe SLD and 2, mild SLD. When SLD was compared with infrainguinal lymphatic disease, 6 limbs (19%) had the same degree of involvement above and below the groin (1 with normal and 5 with severe disease), 17 limbs (55%) had more severe SLD, and 8 limbs (26%) had more severe infrainguinal lymphatic disease. Three limbs with normal pedal lymphoscintigraphic findings had severe SLD. The Spearman correlation coefficient for the comparison of SLD and infrainguinal disease in the same limb was 0.1 (P = .69). At baseline, the limbs with severe SLD had the same degree of leg swelling and venous clinical severity score as the limbs with absent to mild SLD (P > .1) with similar improvements after stenting (P > .4). Seven limbs underwent complex decongestive therapy (all with severe SLD and concomitant severe infrainguinal disease in one) to treat significant residual leg edema, with improvement. CONCLUSIONS: SLD appears to be common in patients with leg edema undergoing stenting for symptomatic CIVO. Such disease appears to affect the thoracic duct more commonly. Although patients with persistent or residual leg edema after stenting can benefit from complex decongestive therapy, further workup in the form of inguinal intranodal lymphangiography and targeted intervention might need to be considered for those who do not benefit from such therapy. Further study is warranted.


Asunto(s)
Enfermedades Linfáticas , Enfermedades Vasculares , Humanos , Femenino , Masculino , Linfografía , Pierna , Ingle , Aceite Etiodizado , Incidencia , Enfermedades Vasculares/diagnóstico por imagen , Enfermedades Vasculares/terapia , Vena Ilíaca/diagnóstico por imagen , Edema/terapia , Stents , Enfermedad Crónica , Resultado del Tratamiento , Estudios Retrospectivos
5.
Phys Ther ; 102(3)2022 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-35079831

RESUMEN

OBJECTIVE: This study aimed to determine the effectiveness of a physical therapist-designed program tailored to axillary web syndrome (AWS) in women after breast cancer surgery. METHODS: A prospective, single-center, assessor-blinded, randomized controlled trial was conducted at the Physiotherapy in Women's Health Research Unit of the Alcalá University (Madrid, Spain). Ninety-six women with AWS were assigned to the physical therapy group (manual lymph drainage [MLD] using resorption strokes and arm exercises as if performing median nerve neurodynamic glide exercises with no neural loading; n = 48) or the control group (standard arm exercises; n = 48), with both groups receiving treatment 3 times a week for 3 weeks. Both interventions included an educational component. RESULTS: Compared with the control group, the physical therapy group showed significant and clinically relevant improvements in the primary outcome (self-reported pain intensity) at the primary and 3-month follow-ups. Significant and clinically relevant differences between groups were also found in the secondary outcomes (shoulder active range of motion, shoulder disability, and physical and functional aspects of health-related quality of life) at the primary follow-up and in the secondary outcomes as well as the trial outcome index at the 3-month follow-up. No significant differences were found at the 6-month follow-up in either primary or secondary outcomes. CONCLUSION: The physical therapy program tailored to AWS was found to be effective for AWS symptoms in women after breast cancer surgery, both immediately after the program and after 3 months. IMPACT: To our knowledge, this is the first appropriately designed study to demonstrate the effectiveness of MLD with progressive arm exercises for AWS. Clinicians and health service providers should consider how to provide survivors of breast cancer with AWS the opportunity to participate in physical therapy programs, including MLD with progressive arm exercises. LAY SUMMARY: For axillary web syndrome following breast cancer surgery, a physical therapist can design a treatment program including manual lymph drainage and progressive arm exercises, which has been shown to result in reduced pain and improved motion compared with standard arm exercises.


Asunto(s)
Neoplasias de la Mama , Enfermedades Linfáticas , Linfedema , Brazo , Axila , Neoplasias de la Mama/cirugía , Femenino , Humanos , Linfedema/diagnóstico , Linfedema/etiología , Linfedema/terapia , Drenaje Linfático Manual , Estudios Prospectivos , Calidad de Vida
6.
Rehabilitacion (Madr) ; 54(4): 276-283, 2020.
Artículo en Español | MEDLINE | ID: mdl-32863012

RESUMEN

The COVID-19 pandemic poses a challenge to the management of non-COVID pathologies such as lymphatic diseases and lipoedema. The use of telemedicine can prevent the spread of the disease. A system is needed to help determine the clinical priority and selection of face-to-face or telemedicine options for each patient and how to carry them out during the pandemic. The Spanish Lymphology Group has drafted a consensus document with recommendations based on the literature and clinical experience, as clinical practice guidelines for the management of lymphatic abnormalities and lipoedema during the COVID-19 pandemic. These recommendations must be adapted to the characteristics of each patient, the local conditions of the centres, and the decisions of health care professionals. The document contains minimum criteria, subject to modifications according to the evolution of the pandemic, scientific knowledge and instructions from health authorities.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus , Lipedema/terapia , Enfermedades Linfáticas/terapia , Pandemias , Neumonía Viral , Telemedicina , COVID-19 , Comorbilidad , Vendajes de Compresión , Continuidad de la Atención al Paciente , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/prevención & control , Manejo de la Enfermedad , Urgencias Médicas , Diseño de Equipo , Necesidades y Demandas de Servicios de Salud , Humanos , Lipedema/complicaciones , Lipedema/rehabilitación , Enfermedades Linfáticas/complicaciones , Enfermedades Linfáticas/rehabilitación , Drenaje Linfático Manual , Visita a Consultorio Médico , Pandemias/prevención & control , Educación del Paciente como Asunto , Participación del Paciente , Modalidades de Fisioterapia , Neumonía Viral/complicaciones , Neumonía Viral/epidemiología , Neumonía Viral/prevención & control , Medicina de Precisión , SARS-CoV-2 , Teléfono , Triaje , Comunicación por Videoconferencia
7.
Minerva Cardioangiol ; 68(3): 197-202, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32586070

RESUMEN

BACKGROUND: The aim of this study was to evaluate the effects of the standardized supplement Robuvit® (oak wood extract) in defined diffuse, minimal lymphatic "retention" (DMLR). METHODS: Robuvit® has already been investigated in both primary and secondary (post-surgical, post chemo-radiotherapy) lymphatic insufficiency. This registry included subjects with diffuse, minimal lymphatic "retention" (DMLR). The registry management groups included women with mild-moderate limb swelling using standard management (SM) as controls. A second, comparable group used prevention with Robuvit® at the dosage of 3 cp/day (300 mg/day) for 4 weeks. RESULTS: No tolerability problems or side effects were observed with the preventive supplementation. The management groups (34 women in total), including 18 women in Robuvit® and 16 in SM were comparable in age and baseline evaluations. After 4 weeks, in the Robuvit® group, edema scale values derived from ultrasound observations decreased significantly (P<0.05) at all measurement's sites, from the proximal (inguinal) level to the more distal (ankle-foot) level. No significant changes in edema were observed in control subjects. Generally, in areas with higher level of edema (distal areas at the foot and ankle), the edema decrease was larger than in more proximal, ultrasound measurement sites. CONCLUSIONS: Preventive Robuvit® supplementation appears to be safe and effective in controlling DMLR in subjects without significant or apparent clinical conditions. This preventive, concept study should be extended to a larger population for more meaningful observations.


Asunto(s)
Edema/tratamiento farmacológico , Taninos Hidrolizables/administración & dosificación , Enfermedades Linfáticas/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Adulto , Edema/diagnóstico por imagen , Edema/patología , Femenino , Humanos , Taninos Hidrolizables/efectos adversos , Taninos Hidrolizables/farmacología , Enfermedades Linfáticas/diagnóstico por imagen , Enfermedades Linfáticas/patología , Persona de Mediana Edad , Extractos Vegetales/efectos adversos , Extractos Vegetales/farmacología , Sistema de Registros , Ultrasonografía
8.
Rofo ; 192(11): 1025-1035, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32215900

RESUMEN

BACKGROUND: Postoperative lymphatic leakage (PLL) is usually managed by conservative and/or surgical treatments but these procedures can be challenging to perform and potentially clinically ineffective. Therefore, conventional lymphangiography (CL) has emerged as an important alternative. The aim of this review is to present the available outcome data on CL in the management of PLL. METHOD: A systematic literature search (PubMed) using the MeSH term "lymphangiography" was performed and the search was restricted to literature published between January 2007 and August 2019. Identification, screening, and assessment for eligibility and inclusion were conducted in accordance with PRISMA. RESULTS: From the initially obtained 1006 articles (identification), 28 articles with a total of 201 patients were finally included (inclusion). The methodological quality of all included articles corresponds to level 4 (Oxford Centre for Evidence-based Medicine - Levels of Evidence, March 2009). PLL occurs after oncological and non-oncological surgery in the form of chylothorax, chylous ascites, and cervical, thoracic, abdominal and peripheral lymph fistula and/or lymphocele. The technical success rate of CL is 75-100 %. Access for CL is transpedal (176 patients) or intranodal (25 patients). Lipiodol is used as the contrast material in all articles, with a maximum amount of 20 ml for transpedal CL and 30 ml for intranodal CL. The X-ray imaging modalities used for CL are fluoroscopy, radiography and/or CT. Two articles report CL-associated major complications and CL-associated morbidity and mortality. The PLL cure rate is 51-70 % for transpedal CL (time to PLL cure: 2-29 days) and 33-100 % for intranodal CL (time to PLL cure: 2-< 30 days). Bailout procedures in the case of clinically ineffective CL include a range of treatments. CONCLUSION: CL is feasible, safe, and effective in the management of PLL. Lipiodol as the contrast material is essential in CL because the highly viscous iodinated poppy-seed oil has not only diagnostic but therapeutic effects. Guidelines and randomized controlled trials are further steps towards defining the ultimate value of CL. KEY POINTS: · PLL is a difficult-to-treat and potentially life-threatening surgical complication.. · CL has emerged as an alternative to conservative/surgical treatment of PLL.. · CL is feasible, safe, and effective in the management of PLL. · Lipiodol-based CL can be regarded as a therapeutic procedure.. · Guidelines and randomized controlled trials are further important steps.. CITATION FORMAT: · Sommer CM, Pieper CC, Itkin M et al. Conventional Lymphangiography (CL) in the Management of Postoperative Lymphatic Leakage (PLL): A Systematic Review. Fortschr Röntgenstr 2020; 192: 1025 - 1035.


Asunto(s)
Enfermedades Linfáticas/diagnóstico por imagen , Enfermedades Linfáticas/terapia , Linfografía , Complicaciones Posoperatorias/diagnóstico por imagen , Complicaciones Posoperatorias/terapia , Quilotórax/diagnóstico por imagen , Quilotórax/terapia , Ascitis Quilosa/diagnóstico por imagen , Ascitis Quilosa/terapia , Aceite Etiodizado/administración & dosificación , Estudios de Factibilidad , Fístula/diagnóstico por imagen , Fístula/terapia , Fluoroscopía , Humanos , Linfocele/diagnóstico por imagen , Linfocele/terapia , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
9.
Ann Surg Oncol ; 27(2): 451-457, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31538289

RESUMEN

BACKGROUND: Patients with recurrent oropharyngeal cancer often require extensive salvage surgery. For patients with clinically N0 necks, the indication for concurrent neck dissection remains unclear. This study aimed to determine predictors, prevalence, and distribution of nodal disease in patients treated with salvage oropharyngectomy. METHODS: In a case series with data collection at a single tertiary academic National Cancer Institute (NCI)-designated comprehensive cancer center, this study analyzed patients treated with prior radiation or chemoradiation who had persistent, recurrent, or second primary squamous cell carcinoma of the oropharynx requiring oropharyngeal resection between 1998 and 2017 (n = 95). Clinical and oncologic characteristics and treatment outcomes were collected, and statistical analyses were performed. RESULTS: The overall rate of nodal positivity was 21% (24/95), and the rate of occult nodal disease was 6% (4/65). Ipsilateral and contralateral level 2 were the most common areas harboring positive nodes. Bivariate analysis showed female sex (p = 0.01), initial overall stage (p = 0.02), and N status (p = 0.03), as well as recurrent overall and T stage (p = 0.05) to be predictors of nodal disease. In the multivariate analysis, recurrent T stage continued to be significantly predictive of pathologic nodal disease. Both computed tomography (CT) and positron emission tomography-CT were moderately accurate in predicting nodal disease in the salvage setting (area under the curve, 0.79 and 0.80, respectively). CONCLUSION: Occult nodal disease is observed in few patients undergoing salvage oropharyngeal resection. This study identified factors predictive of nodal disease in patients undergoing salvage oropharyngectomy and appropriate diagnostic tests in this setting.


Asunto(s)
Carcinoma de Células Escamosas/cirugía , Enfermedades Linfáticas/diagnóstico , Enfermedades Linfáticas/epidemiología , Recurrencia Local de Neoplasia/cirugía , Neoplasias Orofaríngeas/cirugía , Faringectomía/efectos adversos , Terapia Recuperativa/efectos adversos , Canadá/epidemiología , Carcinoma de Células Escamosas/patología , Femenino , Estudios de Seguimiento , Humanos , Ganglios Linfáticos/patología , Enfermedades Linfáticas/etiología , Metástasis Linfática , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/patología , Neoplasias Orofaríngeas/patología , Prevalencia , Pronóstico , Estudios Retrospectivos
10.
Paediatr Respir Rev ; 36: 2-7, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31884062

RESUMEN

Pulmonary lymphatic flow disorders involve the abnormal lymphatic flow via lymphatic channels to the lungs and pleural space. Plastic bronchitis and chylothorax are the main complications of this abnormal lymphatic perfusion, which has been termed pulmonary lymphatic perfusion syndrome (PLPS). Following lymphatic access, dynamic contrast MR lymphangiography is the imaging modality of choice to diagnose these disorders. Management includes medical therapy, percutaneous interventions under fluoroscopy, and surgical interventions.


Asunto(s)
Bronquitis/diagnóstico por imagen , Quilotórax/diagnóstico por imagen , Vasos Linfáticos/diagnóstico por imagen , Linfografía , Imagen por Resonancia Magnética , Adolescente , Bronquitis/terapia , Niño , Preescolar , Quilotórax/terapia , Medios de Contraste , Dietoterapia , Suplementos Dietéticos , Manejo de la Enfermedad , Embolización Terapéutica , Humanos , Lactante , Enfermedades Pulmonares/diagnóstico por imagen , Enfermedades Pulmonares/terapia , Anomalías Linfáticas/diagnóstico por imagen , Anomalías Linfáticas/terapia , Enfermedades Linfáticas/diagnóstico por imagen , Enfermedades Linfáticas/terapia , Vasos Linfáticos/anomalías , Vasos Linfáticos/cirugía , Microcirugia
12.
Khirurgiia (Mosk) ; (3): 135-140, 2019.
Artículo en Ruso | MEDLINE | ID: mdl-30938369

RESUMEN

The issues of absorption, bacterial intestinal metabolism and hepatic metabolism of diosmin are described. The main metabolites of the drug and the ways of their elimination are indicated. The article describes the main therapeutic targets and mechanisms of influence on the course of disease including effect on the venous wall tone and permeability, lymphatic drainage, inflammation and oxidative stress.


Asunto(s)
Diosmina/farmacología , Flavonoides/farmacología , Venas/efectos de los fármacos , Permeabilidad Capilar/efectos de los fármacos , Diosmina/farmacocinética , Flavonoides/farmacocinética , Humanos , Inflamación/tratamiento farmacológico , Enfermedades Linfáticas/tratamiento farmacológico , Enfermedades Linfáticas/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Enfermedades Vasculares/tratamiento farmacológico , Enfermedades Vasculares/fisiopatología , Venas/fisiopatología
14.
J Vasc Interv Radiol ; 30(1): 110-117, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30527658

RESUMEN

PURPOSE: To evaluate polymerization of N-butyl cyanoacrylate (NBCA)/iodized oil mixtures for lymphatic interventions in vitro. MATERIALS AND METHODS: Polymerization times of different NBCA/iodized oil mixtures (ratios of 1:0-1:7) were investigated in a static and dynamic experimental setup (performed in a lymph flow model in a silicone tube). Eight lymphatic samples with different triglyceride (TG) concentrations (low TGs, < 50 mg/dL; medium TGs, approximately 100-400 mg/dL; high TGs, > 700 mg/dL) were investigated. Morphologic changes during NBCA polymerization were monitored and recorded by video. Statistical analysis was performed with intergroup comparisons (Kruskal-Wallis test) and multiple regression analysis. RESULTS: Static experiments showed increasing polymerization times with increasing concentrations of iodized oil as well as increasing concentrations of TGs. In the low-TG group, polymerization time increased from 14 s at a 1:1 ratio of NBCA to iodized oil to 1,336 s at a 1:7 ratio; times in the medium-TG group increased from 21 s (1:1) to 2,546 s (1:7), and those in the high TG group increased from 168 s (1:1) to 16,530 s (1:7). In dynamic experiments, prolongation of polymerization time was less pronounced. For low- and medium-TG groups, total occlusion of the silicon tube was observed in all cases during the embolization procedure at between 26 seconds (1:1 ratio) and 52 seconds (1:7). In the high-TG group, polymerization took considerably longer (between 43 s [1:1] and 467 s [1:7]) or failed completely. CONCLUSIONS: Polymerization time of NBCA/iodized oil in lymph seems to be prolonged by increasing iodized oil and TG concentrations.


Asunto(s)
Embolización Terapéutica/métodos , Enbucrilato/química , Aceite Yodado/química , Enfermedades Linfáticas/terapia , Enbucrilato/administración & dosificación , Humanos , Aceite Yodado/administración & dosificación , Cinética , Linfa/química , Modelos Anatómicos , Polimerizacion , Triglicéridos/química
15.
Phys Ther ; 99(2): 229-239, 2019 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-30339213

RESUMEN

Background and Purpose: Axillary web syndrome (AWS) and seroma are common and function-limiting side effects following treatments for breast cancer. Studies of AWS and seroma are rare, and there are no guidelines for physical therapy in these cases. Case Description: After left breast lumpectomy due to invasive ductal carcinoma, a 65-year-old female patient underwent intraoperative radiation therapy and whole breast radiation. Seven months later, during treatment for breast swelling, AWS and breast seroma were identified by a physical therapist certified in lymphedema treatment. Treatment goals were to reduce breast swelling and pain and to improve shoulder movements. Interventions included manual lymph drainage, left arm stretching, and instruction about self-lymphatic-drainage and stretching exercise. Also, a compression bra was ordered, and continued daily activities and physical activity were recommended. Outcomes: Improvement in shoulder movement, breast swelling, and pain. Discussion: Because evidence for treatment guidelines following treatments for breast cancer is lacking, close follow-up for treatment-related complications is recommended. Management should be chosen according to signs and symptoms. Realistic expectations can reduce patient frustration and improve coping strategies and compliance with self-treatment demands. Clinical studies to support these conclusions are required.


Asunto(s)
Axila/fisiopatología , Enfermedades Linfáticas/terapia , Linfedema/terapia , Mastectomía/efectos adversos , Modalidades de Fisioterapia , Seroma/terapia , Anciano , Femenino , Humanos , Enfermedades Linfáticas/etiología , Complicaciones Posoperatorias/etiología , Seroma/etiología , Síndrome
16.
Artículo en Inglés | WPRIM | ID: wpr-762775

RESUMEN

Orbital tuberculosis is a rare form of extrapulmonary tuberculosis, even in endemic areas. It may involve the soft tissue, lacrimal gland, periosteum, or bones of the orbital wall. We present a case of orbital tuberculosis on the lower eyelid. An 18-year-old woman with no underlying disease visited our clinic for evaluation of an oval nodule (1.5× 1.2 cm) on the right lower eyelid. Incision and drainage without biopsy was performed 2 months ago in ophthalmology department, but the periorbital mass had deteriorated, as the patient had erythematous swelling, tenderness, and cervical lymphadenopathy. Visual acuity was normal; there were no signs of proptosis, diplopia, or ophthalmoplegia. Computed tomography revealed a small abscess cavity without bony involvement. We performed an excision and biopsy through a percutaneous incision under local anesthesia. Histological examination revealed a granuloma and was diagnosed as orbital tuberculosis. The patient was additionally treated with anti-tuberculosis therapy for 6 months and recovered without complication or recurrence by 7 months. Orbital tuberculosis occurs in patients with or without associated pulmonary tuberculosis, and should be considered as a differential diagnosis in patients with inflammatory orbital disease and an orbital mass. If recurrence occurs despite adequate initial treatment, we recommend an additional examination and excisional biopsy.


Asunto(s)
Adolescente , Femenino , Humanos , Absceso , Anestesia Local , Biopsia , Diagnóstico Diferencial , Diplopía , Drenaje , Exoftalmia , Párpados , Granuloma , Aparato Lagrimal , Enfermedades Linfáticas , Oftalmología , Oftalmoplejía , Órbita , Enfermedades Orbitales , Periostio , Recurrencia , Tuberculosis , Tuberculosis Pulmonar , Agudeza Visual
19.
Clin Radiol ; 73(6): 517-525, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29573786

RESUMEN

Cytoreductive surgery (CRS), often associated with hyperthermic intraperitoneal chemotherapy (HIPEC), is now a well-recognised treatment for most peritoneal malignancies in selected patients. As imaging is frequently performed postoperatively, radiologists are increasingly confronted with postoperative multidetector-row computed tomography (MDCT) examinations in these cases. In this article, after briefly describing the procedures that are currently being performed for the treatment of peritoneal metastases, the normal postoperative MDCT changes that may be encountered after these procedures are described. We then highlight complications that may arise after CRS, depending on the surgery performed, and those related to HIPEC, and illustrate their MDCT features.


Asunto(s)
Procedimientos Quirúrgicos de Citorreducción/métodos , Hipertermia Inducida/métodos , Tomografía Computarizada Multidetector/métodos , Neoplasias Peritoneales/diagnóstico por imagen , Cuidados Posoperatorios/métodos , Adulto , Terapia Combinada , Procedimientos Quirúrgicos de Citorreducción/efectos adversos , Diafragma/diagnóstico por imagen , Diafragma/lesiones , Femenino , Humanos , Hipertermia Inducida/efectos adversos , Enfermedades Intestinales/diagnóstico por imagen , Enfermedades Intestinales/etiología , Enfermedades Linfáticas/diagnóstico por imagen , Enfermedades Linfáticas/etiología , Masculino , Persona de Mediana Edad , Enfermedades Pancreáticas/diagnóstico por imagen , Enfermedades Pancreáticas/etiología , Neoplasias Peritoneales/secundario , Neoplasias Peritoneales/cirugía , Complicaciones Posoperatorias/diagnóstico por imagen , Complicaciones Posoperatorias/etiología , Hemorragia Posoperatoria/diagnóstico por imagen , Hemorragia Posoperatoria/etiología , Sistema Urinario/diagnóstico por imagen , Sistema Urinario/lesiones , Enfermedades Vasculares/diagnóstico por imagen , Enfermedades Vasculares/etiología
20.
Arch Environ Occup Health ; 73(3): 140-153, 2018 05 04.
Artículo en Inglés | MEDLINE | ID: mdl-28443719

RESUMEN

Inhaled crystalline quartz is a carcinogen. Analyses show differences in the distribution of lung cancer types depending on the status of silicosis. Using 2,524 lung tumor cases from the WISMUT autopsy repository database, silicosis was differentiated into cases without silicosis in lung parenchyma and its lymph nodes, with lymph node-only silicosis, or with lung silicosis including lymph node silicosis. The proportions of adenocarcinoma, squamous cell carcinoma, and small-cell lung carcinoma mortality for increasing quartz exposures were estimated in a multinomial logistic regression model. The relative proportions of the lung cancer subtypes in lymph node-only silicosis were more similar to lung silicosis than without any silicosis. The results support the hypothesis that quartz-related carcinogenesis in case of lymph node-only silicosis is more similar to that in lung silicosis than in without silicosis.


Asunto(s)
Neoplasias Pulmonares/etiología , Enfermedades Linfáticas/etiología , Mineros , Enfermedades Profesionales/etiología , Exposición Profesional/efectos adversos , Cuarzo/toxicidad , Silicosis/etiología , Adulto , Anciano , Polvo , Alemania/epidemiología , Humanos , Exposición por Inhalación , Neoplasias Pulmonares/epidemiología , Enfermedades Linfáticas/epidemiología , Masculino , Persona de Mediana Edad , Enfermedades Profesionales/epidemiología , Silicosis/epidemiología , Uranio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA